Antibody Engineering & Therapeutics US is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Hua Tu, Ph.D.
undefined at LakePharma, Inc

Profile

Dr. Hua Tu, the founder and CEO of LakePharma, started the company in the San Francisco Bay Area in 2009. He received his academic training at State University of New York at Stony Brook and Cold Spring Harbor Laboratory. After starting his biotech career as a postdoctoral fellow at Tularik, he continued to work on drug development at Tularik and Amgen. His ongoing aspiration is to help bring efficiency and scale to the life science industry.

Agenda Sessions

  • Integrated Solutions for Antibody Engineering and Beyond

    ,
  • In vitro Glycoengineering (IVGE): A Targeted Method to Control Glycosylation of Therapeutic Proteins with a Potential for Higher Protein Yields with Optimized Glycosylation

    ,